Cost analysis of antifungal drugs available in India: A pharmacoeconomic perspective
Journal Title: Indian Journal of Pharmacy and Pharmacology - Year 2016, Vol 3, Issue 4
Abstract
Introduction: Fungal infections are common and treatment imposes economic burden on the patients. The compliance of the patient may be significantly dependent on the cost of the prescribed medicines, especially in developing countries like India. Therefore, this study was conducted to analyze cost variation of drugs used for fungal infections. Aim and Objectives: To evaluate the cost of different brands of anti-fungal drugs available in India, and to analyze the variations in cost of same dosage of different brands of the same active drug. Material and Methods: Cost of a particular drug that is manufactured by different companies, in the same strength, number and dosage forms was obtained from Current Index of Medical Specialties, July-October 2016 and Drug Today, July-September 2016 and were analysed. Cost range, cost ratio and percentage cost variation were calculated. Correlation between percentage cost variation and number of companies manufacturing the drug was analysed by linear regression and Spearman correlation analysis. p < 0.05 was considered statistically significant. Result: The costs of a total of 8 antifungal drugs available in 18 different formulations were analysed and a substantial variation in cost was found. Fourteen drugs had percentage cost variation more than 100%, fluconazole 150 mg (10214%) had maximum percentage cost variation while griseofulvin 500 mg (42%) had minimum percentage cost variation. There was a linear relationship between no. of manufacturing companies and percentage cost variation and Spearman correlation analysis showed a statistically significant positive correlation between these two variables. Conclusion: The present study shows wide variation in the cost of the different brands of the same antifungal drugs manufactured by different companies. This adds to the economic burden for the patients. Ideally, generic drugs should be prescribed to decrease the healthcare cost and to enhance the compliance. Hence, the stakeholders should aim at decreasing the cost variation among different brands while maintaining the therapeutic efficacy.
Authors and Affiliations
Ashutosh Tiwari, Pooja Reddy, Chhaya Goyal
Keywords
Related Articles
- EP ID EP240761
- DOI -
- Views 101
- Downloads 0
Impact of mass media on Knowledge attitude and practices (KAP) amongst the ANC mothers attending the ICTC at DrRPG Medical College, Tanda
Objectives To know the Impact of Mass Media on Knowledge attitude and practices KAP amongst the ANC mothers attending the ICTC at DrRPG Medical College TandaMaterials and MethodsThis was a Hospital based cross sectional...
Knowledge, attitude & practice towards self-medication among nursing students in a teaching hospital of north India
Introduction Selfmedication the use of medication by a patient on his own initiative is increasing widely due to easy accessibility and availability of vast knowledge as a source of information about various drugs more s...
Usefulness of package inserts: Do we really read them!
Introduction: Package inserts (PI) are the required informational leaflets which come along with drug package containing all the necessary and relevant information about the drug. It helps in providing appropriate guidan...
Prevalence, antibiotic resistance pattern and identification of extended spectrum beta-lactamase producing Klebsiella pneumoniae by phenotypic and genotypic method from various clinical samples
The present study is about ESBL producing Klebsiella pneumoniae which is diagnosed by phenotypic and genotypic methods A total of 5055 properly collected well labelled samples received in the Microbiology laboratory were...
Pharmacovigilance awareness among the teaching staffs of a medical college in Karnataka: a cross sectional study
Background: Pharmacovigilance deals with adverse drug reactions and required for early detection and prevention of drug-related morbidity and mortality. The objective of the present is to evaluate the Pharmacovigilance a...